免疫抑制与脓毒症诱导的弥散性血管内凝血恶化相关
这项前瞻性观察研究在三级学术医院纳入640例脓毒症患者,按ISTH评分分为无DIC组(383例,ISTH=0)、非显性DIC组(168例,ISTH=1-4)和显性DIC组(89例,ISTH≥5),在入组第1、3、7天检测18项免疫相关标志物和6项常规凝血指标。结果显示,脓毒症患者凝血障碍发生率为40%,显性DIC发生率为14%。显性DIC患者从第1天到第7天表现出明显的免疫紊乱,包括单核细胞HLA-DR(mHLA-DR)百分比降低、调节性T细胞百分比升高,以及降钙素原、中性粒细胞CD64指数和全身炎症细胞因子水平升高。多因素分析显示,入组第1天抗炎细胞因子IL-10与mHLA-DR联合对脓毒症DIC恶化具有较好的预测价值(AUC=0.87,P<0.0001)。作者认为免疫抑制可能与凝血障碍在脓毒症中相互作用,并提供一个额外的评估工具来预测DIC恶化。
要点
- 640例脓毒症患者中,凝血障碍发生率为40%,显性DIC(ISTH≥5)发生率为14%。
- 显性DIC患者从第1天到第7天mHLA-DR百分比降低、调节性T细胞百分比升高,降钙素原、中性粒细胞CD64指数和全身炎症细胞因子水平升高。
- 入组第1天IL-10与mHLA-DR联合预测脓毒症DIC恶化,AUC=0.87,P<0.0001。
- 研究按ISTH评分分组:无DIC组383例(ISTH=0)、非显性DIC组168例(ISTH=1-4)、显性DIC组89例(ISTH≥5)。
适用人群与场景
- 脓毒症患者,按ISTH评分分为无DIC组(ISTH=0,383例)、非显性DIC组(ISTH=1-4,168例)和显性DIC组(ISTH≥5,89例)。
- 研究在三级学术医院进行,为前瞻性观察研究。
诊断标准与关键阈值
- 采用国际血栓与止血学会(ISTH)评分对脓毒症患者进行DIC分类:ISTH=0为无DIC,ISTH=1-4为非显性DIC,ISTH≥5为显性DIC。
研究设计与关键结果
- 研究类型为前瞻性观察研究,纳入640例脓毒症患者,在入组第1、3、7天检测18项免疫相关标志物和6项常规凝血指标。
- 脓毒症患者中凝血障碍发生率为40%,显性DIC发生率为14%。
- 显性DIC患者从第1天到第7天表现出明显的免疫紊乱:mHLA-DR百分比降低、调节性T细胞百分比升高,降钙素原、中性粒细胞CD64指数和全身炎症细胞因子水平升高,均相对于非显性DIC或无DIC患者。
- 多因素分析中,入组第1天抗炎细胞因子IL-10与mHLA-DR联合对预测脓毒症DIC恶化具有较好的预测价值(AUC=0.87,P<0.0001)。
证据类型、等级与局限
- 证据类型:前瞻性观察研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为免疫抑制可能与脓毒症中的凝血障碍相互作用,并提供额外的评估工具来预测DIC恶化。
- 入组第1天IL-10与mHLA-DR联合可能用于预测脓毒症患者DIC恶化(AUC=0.87,P<0.0001)。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Background: The dysregulated host responses play a crucial role in the pathophysiology process of sepsis-induced disseminated intravascular coagulation (DIC). The study aimed to characterize the dynamic alternation of immune-related biomarkers and their relationship with the progression of DIC during sepsis. Methods: A prospective, observational study was conducted in a tertiary care academic hospital. Six hundred forty patients with sepsis were classified into three groups according to the International Society on Thrombosis and Hemostasis (ISTH) score: 383 involved patients without DIC (ISTH = 0), 168 sepsis with nonovert DIC (ISTH = 1-4), and 89 sepsis with overt DIC (ISTH ≥5). Eighteen immune-related biomarkers and six routine coagulation variables were examined at D1, D3, and D7 upon enrollment. The association between the immune parameters and the DIC deterioration was assessed during sepsis. Results: The study showed a 40% coagulation disorder and a 14% incidence of overt DIC in patients with sepsis. The patients with overt DIC displayed pronounced immune disorders from D1 to D7 upon sepsis, which was characterized by the decreased percentage of monocyte HLA-DR (mHLA-DR), increased percentage of regulatory T cells, the levels of procalcitonin, neutrophil CD64 index, and systemic inflammatory cytokines relative to nonovert DIC or non-DIC patients. In multivariate analysis, the combination of anti-inflammatory cytokine IL-10 and mHLA-DR at D1 upon enrollment had a superior predictive value for predicting DIC deterioration in sepsis (area under the curve = 0.87, P < 0.0001). Conclusion: These data illustrate that immunosuppression can crosstalk with coagulation disorder during sepsis and present an additional evaluation tool to predict DIC deterioration.
参考来源
- Sun Y, Sun H, Feng J, et al. IMMUNOSUPPRESSION CORRELATES WITH THE DETERIORATION OF SEPSIS-INDUCED DISSEMINATED INTRAVASCULAR COAGULATION. Shock. 2024. PMID: 36735379. doi:10.1097/SHK.0000000000002069
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。